Therapy: What evidence should guide the use of thiazolidinediones?
Riddle
Matthew C
MC
Oregon Health & Science University, Division of Endocrinology, Diabetes & Clinical Nutrition L-345, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239-3098, USA. riddlem@ohsu.edu
D002318:Cardiovascular Diseases / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D045162:Thiazolidinediones; D000077154:Rosiglitazone